These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Has knowledge of atherosclerosis advanced sufficiently to warrant its application to a practical prevention program? The 1970 G. Lyman Duff Memorial Lecture, Council on Arteriosclerosis, American Heart Association. Katz LN Circulation; 1972 May; 45(5):8-20. PubMed ID: 5020805 [No Abstract] [Full Text] [Related]
6. The unstable atheromatous plaque. Arroyo LH; Lee RT Can J Cardiol; 1998 May; 14 Suppl B():11B-13B. PubMed ID: 9627536 [TBL] [Abstract][Full Text] [Related]
7. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?]. Castaigne A; Haziza F; Lopes-Darmon ME Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081 [TBL] [Abstract][Full Text] [Related]
8. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension]. Gysan DB Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218 [TBL] [Abstract][Full Text] [Related]
9. [Recommendations for comprehensive risk reduction for patients with coronary heart disease, vascular diseases and diabetes. Distributed by the leadership of the German Society of Cardiology-Heart- and Vascular Research. Produced by request of the Committee of Clinical Cardiology by the Prevention Project Group]. Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G; Z Kardiol; 2002; 91 Suppl 2():61-2. PubMed ID: 12436766 [No Abstract] [Full Text] [Related]
10. Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis. Polasek J Can J Cardiol; 1997 May; 13(5):533-5. PubMed ID: 9179093 [TBL] [Abstract][Full Text] [Related]
15. The paediatric origins of atherosclerosis. Evans GR; Taylor KG Br J Hosp Med; 1988 Feb; 39(2):132-7. PubMed ID: 3359081 [TBL] [Abstract][Full Text] [Related]
16. [Drug therapy in the secondary prevention of atherosclerosis]. Kettunen R Duodecim; 2002; 118(20):2093-101. PubMed ID: 12463000 [No Abstract] [Full Text] [Related]
17. [Protocol of the GISSI-prevention study. Study of preventive intervention in the atherosclerotic and thrombotic components of post-infarction risk]. G Ital Cardiol; 1993 Oct; 23(10):1053-61. PubMed ID: 8174859 [No Abstract] [Full Text] [Related]
18. [Antihypertensive therapy in secondary prevention of atherosclerosis]. Witzgall H Internist (Berl); 1989 May; 30(5):291-6. PubMed ID: 2661471 [No Abstract] [Full Text] [Related]
19. [Pyridinol carbamate, a new approach in the prevention and therapy of atherosclerosis]. Etchevés JC; Buzzi RM; Bruno E; Sacanell C Hospital (Rio J); 1968 Sep; 74(3):807-14. PubMed ID: 5310120 [No Abstract] [Full Text] [Related]
20. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Bhatt DL; Topol EJ; Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]